mortality. 1 According to Laplace's law, in the short-term, increases in LV mass (LVM) may be beneficial by allowing for a reduction in LV wall stress and hemodynamic compromise. On the other hand, in the long-term, LV geometric abnormalities, particularly LVH, can deteriorate to maladaptive processes and increase the risk of HF and other CV disorders. 2 Clearly, numerous epidemiological studies have demonstrated that LVH is not benign but is associated with very high prevalence of morbid CV events, and in most instances, LVH seems to be a more potent risk factor than other conventional CV risk factors for predicting major CV morbidity and mortality.
1, [3] [4] [5] [6] In this review, we discuss the various types of LV geometric abnormalities, including concentric remodeling (CR) and concentric and eccentric LVH (cLVH and eLVH, respectively). We also review the risk factors for LVH, its consequences, and implications for regression. Additionally, we review the more subtle LV geometric abnormality of CR and its predictive value for CV events, as well as implications for preventing the conversion of CR to frank LVH. Finally, we discuss the impact of obesity on LV geometric abnormalities and the association of LV geometric abnormalities with other structural abnormalities, particularly left atrial enlargement (LAE).
Risk Factors
A C C E P T E D M A N U S C R I P T
ACCEPTED MANUSCRIPT
The major risk factors for LVH are listed in 12 Additionally, high sodium intake, independent of level of BP, also increases the prevalence of LVH, 1, 7 as do other factors listed in Table 1 .
Consequences of LVH
As discussed earlier, although initially LVH may be compensatory and benign, for decades it has been known to be associated with numerous adverse CV consequences (Table 2 and Figure 1 ).
More than 3 decades ago, data from the Framingham Heart Study demonstrated that definite electrocardiographic (ECG) evidence of LVH, both by voltage and with repolarization abnormalities or "strain" pattern on the EGC, was associated with 6-fold and 8-fold increases in CHD and CV mortality, respectively. 10 Clearly, as LVH as assessed by LVM index (LVMI) increases, so does the risk of major CV events.
Coronary Flow Reserve (CFR) The ability of the coronary arteries to increase their blood flow under stress is referred to as CFR, which is markedly reduced in patients with LVH due to HTN or aortic stenosis.
1,13
A C C E P T E D M A N U S C R I P T Additionally, LVH is a strong risk factor for atrial fibrillation (AF), 17, 18 including a 20% increase in the risk of AF for every one standard deviation increase in LVM. 17 Also, ECG-LVH appears to be an independent risk factor for AF, 18 whereas regression of ECG-LVH was associated with reduced risk of AF.
A C C E P T E D M A N U S C R I P T ACCEPTED MANUSCRIPT
Increased CV Events Early studies from the Framingham Heart Study demonstrate marked increases in CHD events, HF, and SCD associated with ECG-LVH. 10 During the last three decades, two studies from the Framingham Heart Study 3,20 and elsewhere 4, 6 all clearly demonstrate marked increases in CV morbidity and mortality associated with echocardiographic LVH. 1, 7 Typically, studies have demonstrated a greater increase in CV risk across the spectrum of LVM and LVH. 1, 21 The risk associated with specific LV geometric profiles is discussed below.
In addition to CV diseases, LVH also appears to be associated with and predictive of renal endpoints and other target organ damage. 1, 22 However, despite the very strong association of LVH with CV and non-CV risk, LVH is not often included as a standard CV disease risk factor.
Specific Abnormalities in LV Geometry
Typically, HTN and other CV disorders can include 4 distinct patterns of LV geometry based on the relationship between LV cavity size and RWT, including CR, as well as eLVH and cLVH ( Figure 2 ). 
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Alterations in LV geometry other than LVH have not typically been appreciated as important CV risk factors. 1, 25 However, many studies have demonstrated that specific LV geometry and type of LVH may be an important factor in CV diseases, including HTN ( Figure 3) . 4 In fact, Koren et al 4 ,in a large study of patients with HTN, demonstrated an over 2-fold increase in CV events in those with CR compared with normal LV geometry, with CV events markedly and progressively increasing with eLVH and cLVH.
Recently, we have assessed the prevalence of abnormal LV geometry in echocardiographic patients with normal left ventricular ejection fraction (LVEF), defined as ≥ 50%, demonstrating that over one-third had CR, and over 10% had echocardiographic LVH, almost evenly divided between eLVH and cLVH. 25 In a study of 35,602 patients with normal LVEF, Milani et al 25 demonstrated marked increases in mortality associated with CR, similar to that noted with eLVH, with a further marked increase in mortality with cLVH ( Figure 4 ). Since patients with reduced LVEF or advanced valvular heart disease were not included in this study, eLVH may not carry as high of a risk compared with some HF or valvular heart disease studies. In a study by Lavie et al 26 in patients > 70 years of age, CR was present in 43% of elderly, and in this elderly cohort, CR and cLVH were associated with marked increases in mortality compared with normal LV geometry and even more than those with eLVH.
Impact of Obesity

A C C E P T E D M A N U S C R I P T ACCEPTED MANUSCRIPT
As previously discussed, obesity is one of the strongest predictors for abnormal LV geometry, including LVH, and typically obesity increases with age and is a strong risk factor for HTN. 1, 7, 27 Clearly, we have recently demonstrated that abnormal LV geometry, including both CR and both eLVH and cLVH, are more common in obese than leaner patients, with the same impact of obesity on abnormal LV geometry noted in both women and men. 27, 28 Additionally, we have identified a strong "obesity paradox" in many cohorts with CV diseases, as discussed in detail elsewhere. [29] [30] [31] [32] Despite the increased prevalence of abnormal LV geometry in obesity, which is typically associated with worse overall CV prognosis, we still demonstrated better survival among obese men and women compared to their leaner counterparts. 27, 28 In fact, for every LV geometric profile (normal LV geometry, CR, eLVH and cLVH), obese had lower mortality than did the leaner patients ( Figure 5 ). 28 In our studies, we define LV geometry as recommended by the ASE and as used in many trials, and we indexed LVM to body surface area (BSA), using the LVMI method. 24 However, many obesity researchers have suggested correcting LVM for some height or other allometric correction (e.g. height 2.7 , using a cut-off of 50 g/m 2.7 to define LVH) that may correlate better with lean body mass and reduce the variability in cohorts of normal subjects. 1, 33 Nevertheless, in our laboratory, correcting LVM for either BSA or height had similar prognostic power in obese and lean patients, and the BSA method predicted mortality slightly better than did the height method. 27, 28 LV Geometry and Left Atrial Enlargement
It is well known that there is a close relationship between left atrial enlargement (LAE) and DD.
Although numerous methods to assess DD by echocardiography are available, including pulsedDoppler of mitral inflow and mitral annular tissue Doppler imaging , 35 which are beyond the context of this manuscript, a common result of many LV structural and functional abnormalities, including DD, is LAE . [35] [36] [37] .Likewise, studies indicate that LVH is an independent predictor of LA size. 35 In a study of 47,865 patients with LVEF ≥50%, we determined that both RWT and LVMI were independent predictors of LAE. Although CR was associated with slight, but significant, increase in the prevalence of LAE, both eLVH and cLVH, were associated with twofold increases in the prevalence of LAE. Furthermore, LAE was independently associated with abnormalities in LV geometry. 35 Prior studies have indicated that LAE as assessed by left atrial volume index ( LAVI ) was a powerful predictor of survival in patients with CV diseases. 36 In a similar way, the combination of abnormal LV geometry and LAE in our study was associated with additive effects on increasing all-cause mortality. 37 Mild, moderate and severe LAE by LAVI were associated with 10%, 46% and 2.5-fold increased risk of mortality, respectively. 37 In patients with normal LV geometry or CR, severe LAE was associated with increased mortality by 28% and 46%, respectively. However, in eLVH and cLVH, the mortality risk with severe LAE was twice that of patients with a normal LAVI. 37 Regression of Abnormal LV Geometry
It is well known from both animal and human studies that anti-HTN therapies may cause regression of LVH and could be associated with reductions in CV morbidity and mortality. 
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